Ken Griffin 10x Genomics, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$15.71 - $23.49 $617,403 - $923,156	39,300 Added 150.0%	65,500 $1.48 Million
Q2 2024 Aug 14, 2024	SELL	$19.45 - $37.37 $1.6 Million - $3.07 Million	-82,100 Reduced 75.81%	26,200 $509,000
Q1 2024 May 15, 2024	BUY	$36.08 - $54.3 $187,616 - $282,360	5,200 Added 5.04%	108,300 $4.06 Million
Q4 2023 Feb 14, 2024	SELL	$34.32 - $57.55 $1.35 Million - $2.26 Million	-39,300 Reduced 27.6%	103,100 $5.77 Million
Q3 2023 Nov 14, 2023	BUY	$40.86 - $62.98 $1.64 Million - $2.53 Million	40,200 Added 39.33%	142,400 $5.87 Million
Q2 2023 Aug 14, 2023	BUY	$50.96 - $58.72 $1.61 Million - $1.85 Million	31,500 Added 44.55%	102,200 $5.71 Million
Q1 2023 May 15, 2023	BUY	$35.33 - $55.79 $1.81 Million - $2.85 Million	51,100 Added 260.71%	70,700 $3.94 Million
Q4 2022 Feb 14, 2023	SELL	$24.4 - $41.3 $1.2 Million - $2.03 Million	-49,200 Reduced 71.51%	19,600 $714,000
Q3 2022 Nov 14, 2022	BUY	$28.48 - $52.59 $1.07 Million - $1.97 Million	37,500 Added 119.81%	68,800 $1.96 Million

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.33B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.